Astrazeneca PLC (
) will begin trading ex-dividend on August 14, 2013. A cash
dividend payment of $0.9 per share is scheduled to be paid on
September 16, 2013. Shareholders who purchased AZN stock prior to
the ex-dividend date are eligible for the cash dividend payment.
This represents an -52.63% decrease from the prior quarter.
The previous trading day's last sale of AZN was $51,
representing a -4.58% decrease from the 52 week high of $53.45 and
a 15.46% increase over the 52 week low of $44.17.
AZN is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). AZN's current earnings per share, an indicator of a company's
profitability, is $3.9. Zacks Investment Research reports AZN's
forecasted earnings growth in 2013 as -24.73%, compared to an
industry average of -3.7%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to AZN through an Exchange
Traded Fund [ETF]?
The following ETF(s) have AZN as a top-10 holding:
- Merrill Lynch Pharmaceutical HOLDRS (
- FlexShares International Quality Dividend Dynamic Index Fund
- FlexShares International Quality Dividend Defensive Index
- FlexShares International Quality Dividend Index Fund (
The top-performing ETF of this group is PPH with an increase of
8.6% over the last 100 days. It also has the highest percent
weighting of AZN at 4.39%.